Nur77: Orphaned at birth but adopted by the nuclear factor κb signaling pathway

Circulation Research

Volumn 104, Issue 6, 2009, Pages 707-709

  Evans, Paul C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; NUCLEAR RECEPTOR NUR77; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; DNA BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; STEROID RECEPTOR;

ANGIOGENESIS; ATHEROSCLEROSIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; EDITORIAL; ENDOTHELIUM CELL; HUMAN; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ADENOVIRUS; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL STRAIN U937; DNA RESPONSIVE ELEMENT; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; METABOLISM; MONOCYTE; MUTATION; NOTE; TIME;

ADENOVIRIDAE; CARDIOVASCULAR DISEASES; CELL ADHESION; CELL PROLIFERATION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; MONOCYTES; MUTATION; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, STEROID; RESPONSE ELEMENTS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 64249110598     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.195529     Document Type: Editorial

References (19)

1. Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008;454:470-477.
2. You B, Jiang Y-Y, Chen S, Yan G, Sun J. The orphan nuclear receptor Nur77 suppresses endothelial cell activation through induction of IB expression. Circ Res. 2009;104:742-749.
3. Milbrandt J. Nerve growth-factor induces a gene homologous to the glucocorticoid receptor gene. Neuron. 1988;1:183-188.
4. Pols TWH, Bonta PI, de Vries CJM. NR4A nuclear orphan receptors: protective in vascular disease? Curr Opin Lipidol. 2007;18:515-520.
5. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
6. Bonta PI, van Tiel CM, Vos M, Pols TWH, van Thienen JV, Ferreira V, Arkenbout EK, Seppen J, Spek CA, van der Poll T, Pannekoek H, de Vries CJM. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol. 2006;26:2288-2294.
7. Pei LM, Castrillo A, Chen MY, Hoffmann A, Tontonoz P. Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem. 2005;280:29256-29262.
8. Arkenbout EK, de Waard V, van Bragt M, van Achterberg TAE, Grim-bergen JM, Pichon B, Pannekoek H, de Vries CJM. Protective function of transcription factor TR3 orphan receptor in atherogenesis - Decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation. 2002;106:1530-1535.
9. de Vries CJM, van Achterberg TAE, Horrevoets AJG, ten Cate JW, Pannekoek H. Differential display identification of 40 genes with altered expression in activated human smooth muscle cells - Local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes. J Biol Chem. 2000;275:23939-23947.
10. de Waard V, Arkenbout EK, Vos M, Mocking AIM, Niessen HWM, Stooker W, De Moo BAJM, Quax PHA, Bakker ENTP, VanBavel E, Pannekoek H, de Vries CJM. TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells. Am J Path. 2006;168:2027-2035.
11. Pires NMM, Pols TWH, de Vries MR, van Tiel CM, Bonta PI, Vos M, Arkenbout EK, Pannekoek H, Jukema JW, Quax PHA, de Vries CJM. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. Circulation. 2007;115:493-500.
12. Arkenbout EK, van Bragt M, Eldering E, van Bree C, Grimbergen JM, Quax PHA, Pannekoek H, de Vries CJM. TR3 orphan receptor is expressed in vascular endothelial cells and mediates cell cycle arrest. Arterioscler Thromb Vasc Biol. 2003;23:1535-1540.
13. Liu D, Jia HY, Holmes DIR, Stannard A, Zachary I. Vascular endothelial growth factor-regulated gene expression in endothelial cells - KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler Thromb Vasc Biol. 2003;23:2002-2007.
14. Zeng HY, Qin LL, Zhao DZ, Tan XL, Manseau EJ, Hoang MV, Senger DR, Brown LF, Nagy JA, Dvorak HF. Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med. 2006;203:719-729.
15. Kanters E, Gijbels MJJ, van der Made I, Vergouwe MN, Heeringa P, Kraal G, Hofker MH, de Winther MPJ. Hematopoietic NF-kappa B1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood. 2004;103:934-940.
16. Kanters E, Pasparakis M, Gijbels MJJ, Vergouwe MN, Partouns-Hendriks I, Fijneman RJA, Clausen BE, Forster I, Kockx MM, Rajewsky K, Kraal G, Hofker MH, de Winther MPJ. Inhibition of NF-kappa B activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2003;112:1176-1185.
17. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJJ, Kardakaris R, Polykratis A, Kollias G, de Winther MPJ, Pasparakis M. Endothelial cell-specific NF-kappa B inhibition protects mice from atherosclerosis. Cell Metab. 2008;8:372-383.
18. Hayden MS, Ghosh S. Signaling to NF-kappa B. Genes Dev. 2004;18: 2195-2224.
19. Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, Cybulsky MI. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci U S A. 2000;97:9052-9057.